Oxaliplatin In Operable Colorectal CancerA Viewpoint by Gérard Milano

被引：0
|
作者：
Gérard Milano
机构：
[1] Centre Antoine Lacassagne,Oncopharmacology Unit
来源：
Drugs | 2005年 / 65卷
关键词：
Vascular Endothelial Growth Factor; Epidermal Growth Factor Receptor; Irinotecan; Oxaliplatin; Leucovorin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 97
相关论文
共 33 条
  • [1] Oxaliplatin In Operable Colorectal CancerA Viewpoint by Jacques Wils
    Jacques Wils
    Drugs, 2005, 65 (1) : 97 - 98
  • [2] Oxaliplatin in operable colorectal cancer - A viewpoint
    Wils, J
    DRUGS, 2005, 65 (01) : 97 - 98
  • [3] Oxaliplatin - In operable colorectal cancer
    Keam, SJ
    Dunn, CJ
    Figgitt, DP
    DRUGS, 2005, 65 (01) : 89 - 96
  • [4] ButenafineA Viewpoint by Gérald Piérard
    Gérald Piérard
    Drugs, 1998, 55 (3) : 413 - 413
  • [5] Hexyl Aminolevulinate in the Detection of Bladder CancerA Viewpoint by Dirk Zaak and Christian G. Stief
    Dirk Zaak
    Christian G. Stief
    Drugs, 2006, 66 (4) : 579 - 580
  • [6] Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancerA single center experience
    Roberto Díaz
    Jorge Aparicio
    Jorge Molina
    Laura Palomar
    Alejandra Giménez
    José Ponce
    Ángel Segura
    José Gómez-Codina
    Medical Oncology, 2006, 23 : 347 - 357
  • [7] Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancerA multicenter non-randomized phase II study
    Daniele Santini
    Cristian Massacesi
    Rolando Maria D’Angelillo
    Fabiana Marcucci
    Costantino Campisi
    Bruno Vincenzi
    Alberta Pilone
    Vincenzo Bianco
    Maurizio Bonsignori
    Giuseppe Tonini
    Medical Oncology, 2004, 21 : 59 - 66
  • [8] Targeting delivery of oxaliplatin with smart PEG-modified PAMAM G4 to colorectal cell line: In vitro studies
    Narmani, Asghar
    Kamali, Mehdi
    Amini, Bahram
    Salimi, Ali
    Panahi, Yunes
    PROCESS BIOCHEMISTRY, 2018, 69 : 178 - 187
  • [9] PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin
    Li, Ajian
    Chen, Hui
    Lin, Moubin
    Zhang, Chenbo
    Tang, Erjiang
    Peng, Jian
    Wei, Qing
    Li, Huaguang
    Yin, Lu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 1137 - 1143
  • [10] MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Jee Hyun Park
    Nung Soo Kim
    Jae Yong Park
    Yee Soo Chae
    Jong Gwang Kim
    Sang Kyun Sohn
    Joon Ho Moon
    Byung Woog Kang
    Hun Mo Ryoo
    Sung Hwa Bae
    Gyu Seog Choi
    Soo-Han Jun
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1135 - 1142
1234